Business Wire

GSMA Partnership Programme Expands to Create the Largest IoT Community in Asia Pacific

25.9.2019 08:00:00 EEST | Business Wire | Press release

Share

The GSMA APAC IoT Partnership Programme has expanded to include more than thirty mobile operators making it the largest IoT community in the Asia Pacific region (APAC), the GSMA announced today. The programme brings operators and their partners together including developers, manufacturers and system integrators to share best practice, discuss challenges and progress updates on the development of IoT across the region. The initiative has seen 7 operators open 9 new IoT Labs in the region to help develop new IoT-based solutions. APAC has the largest IoT market in the world and is expected to reach 11 billion connections by 2025 and be worth $386 billion, according to GSMA Intelligence.

“The programme has doubled in size in less than a year and that is testament to the support, engagement and commitment of the mobile operator community who are collaborating closely with their partners to lead the expansion and growth of IoT across the region,” said Julian Gorman, Head of Asia Pacific, GSMA. “This is now the largest cross-regional IoT community in the world and we are already seeing the impact it is having in terms of the development of new solutions. I look forward to seeing how it continues to grow in the coming years.”

APAC Impact

Since launch in October 2018, the APAC IoT Partnership Programme has had an instant impact throughout the region, encouraging more than 120 companies such as IoT developers or solutions companies to work with operators. The programme has also supported the development, design and funding of 9 new IoT Labs throughout the region that is encouraging the development of new products. The IoT labs are a key mechanism for collaboration, encouraging the joint development of new use cases, services and applications that are enabling IoT innovations to be effectively deployed. The programme has also held a series of workshops exploring key industry topics such as Mobile IoT, AI and 5G as well as offered capacity building for local regulators and stakeholders and provided best practice support.

Mobile IoT Experiencing Fastest Global Growth

The APAC region is the fastest growing IoT market in the world, accounting for approximately 40 per cent of the total global IoT spend in 2018. Global Low Power Wide Area (LPWA) or Mobile IoT network connections have also been driven primarily by the APAC region accounting for nearly 97% of all NB-IoT connections according to ABI Research. Mobile IoT networks are being merged into 5G standards to support low latency, massive IoT and large bandwidth. Thirty-seven of the world’s 119 Mobile IoT networks are also deployed in Asia Pacific across 15 countries. China in particular has been a key market in driving early adoption, accounting for 40 per cent of the global LPWA connections in 2018.

IoT @ GSMA Mobile 360 – Digital Societies

The GSMA IoT programme will host a number of different activities at GSMA M360 – Digital Societies held in Kuala Lumpur on Thursday 26 September 2019. This includes the APAC IoT Innovation Summit which provides attendees with insight from mobile operators and their partners on the latest developments in Mobile IoT. There will also be a number of interactive demos showcasing Mobile IoT, 5G, AI, Big Data Analytics, Blockchain and Drones at IoT Expo – Connected APAC. This will include hands on demonstrations from key industry verticals such as agriculture, aviation and retail and host smart home, smart traffic and smart poultry solutions. For further information, please go here: https://www.gsma.com/iot/events/m360-apac-iot-summit/#expo

The Birth of Beyond Connectivity

The GSMA will launch the ‘Beyond Connectivity’ campaign at Mobile 360 – Digital Societies. Beyond Connectivity describes how mobile operators are delivering innovation and transformative solutions to customers across big data, machine learning, analytics, edge computing and distributed ledger technologies and delivering beyond just data connectivity. To find out more, please go to: www.gsma.com/BeyondConnectivity

-ENDS-

Notes to Editors

  1. Operators include Axiata Group (Axiata Robi, Celcom, Dialog Axiata, Ncell, Smart Axiata, XL Axiata and Xpand), Indosat Ooredoo, Jazz, M1, Maxis, Mobitel, Smartfren, Singtel Group (Singtel, Optus), StarHub, Telenor Group (Digi, DTAC, Grameenphone, Telenor Connexion, Telenor Myanmar, Telenor Pakistan), Telstra, TM ONE, True, Rakuten, Viettel Group (Metfone, Mytel, Unitel, Viettel), Vodafone Idea

About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators and nearly 400 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For the GSMA
Gearóid Cashman
+44 79 7679 0169
GCashman@webershandwick.com

GSMA Press Office
pressoffice@gsma.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye